Slingshot members are tracking this corporate initiative:
Ipsen (IPSEY) Agrees to Acquire Some of Merrimack's (MACK) Oncology Assets, Including Pancreatic Cancer Drug Onivyde, For Up to $1 Billion
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Jan 09, 2017 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Oncology Assets, Pancreatic Cancer, Onivyde